GU CONNECT expert, Assoc. Prof. Shilpa Gupta provides a urothelial cancer update from ASCO GU 2020 for you.
Urothelial cancer update by Assoc. Prof. Shilpa Gupta, University of Minnesota, Minneapolis, USA
GU CONNECT expert, Assoc. Prof. Shilpa Gupta provides a urothelial cancer update from ASCO GU 2020 for you.
Urothelial cancer update by Assoc. Prof. Shilpa Gupta, University of Minnesota, Minneapolis, USA
Shilpa Gupta, MD is an Associate Professor in the Division of Hematology, Oncology and Transplantation and the lead for the Phase 1 Interdisciplinary Solid Tumor Program at the Masonic Cancer Center, University of Minnesota, Minneapolis, USA. Prior to joining the University of Minnesota in July 2015, Dr Gupta was faculty in Genitourinary Oncology and Experimental Therapeutics at the H. Lee Moffitt Cancer Center and Research Institute in Tampa, Florida for 4 years. Dr Gupta’s clinical and research interests are to treat patients with genitourinary malignancies and develop novel trials using targeted therapies and immunotherapies. She is currently the Principal investigator of several early and late phase trials in genitourinary oncology. Dr Gupta is passionate about her research and has published her research across a variety of peer-reviewed journals and book chapters. Twitter: @shilpaonc Email:guptash@umn.edu
Early treatment intensification with a PARPi plus ARPI combination
Module 2 - Evolving landscape of PARPi in mCRPC: Combination with anti-androgens
Episode 2: Clinical implementation of testing and PARP inhibitors in combination with NHAs
Episode 1: Clinical implementation of testing and PARPi monotherapy
A podcast from GU oncology experts
Experts join us at ESMO 2026 to share their insights on new data on GI, liver, lung, breast and GU cancers